Jones Financial Companies’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Buy
9,094
+1,154
+15% +$15.3K ﹤0.01% 2767
2026
Q1
$103K Buy
7,940
+6,837
+620% +$103K ﹤0.01% 2661
2025
Q4
$19.9K Buy
1,103
+82
+8% +$1.47K ﹤0.01% 2934
2025
Q3
$19K Hold
1,021
﹤0.01% 2826
2025
Q2
$16.2K Sell
1,021
-203
-17% -$3.62K ﹤0.01% 2688
2025
Q1
$23.8K Buy
+1,224
New +$25.8K ﹤0.01% 2364

Other funds holding CLBT

Jones Financial Companies's CLBT Position: Q2 2026 in Review

Jones Financial Companies increased its Cellebrite (CLBT) stake by 15% in Q2 2026, buying an estimated $15.3K and bringing the position to 9,094 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #2767.

Jones Financial Companies first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jones Financial Companies held 9,094 shares of Cellebrite worth $125K as of Q2 2026.
  • Jones Financial Companies bought 1,154 Cellebrite shares in Q2 2026, an estimated $15.3K.
  • Cellebrite made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2767 holding.
  • Jones Financial Companies first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.